CNBC Television
@CNBCtelevision·3.4M subscribers·157.5K videos
Novo Nordisk CEO: We are a cardiometabolic powerhouse
Posted
June 9, 2026
Views
726
Likes
14
Comments
2
Engagement
2.20%
June 9, 2026
726
14
2
2.20%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
10:49Now PlayingAt the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Novo Nordisk CEO Mike Doustdar to discuss what to expect from Novo’s pipeline and strategy in the years to come. “We're going to be very diversified,” he says. “But all of it within the area of cardiometabolics, per se. Diabetes, obesity, cardiometabolic, and some of the adjacencies.”
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
